![Matthew Balk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Balk
Keine laufenden Positionen mehr
Profil
Matthew Balk is the founder of Entero Therapeutics, Inc. Mr. Balk was an Independent Director at Vivakor, Inc. from 2020 to 2023.
Mr. Balk was a Director at Adapti, Inc. from 2024 to 2025.
Balk earned an MBA from The Leonard N Stern School of Business.
Ehemalige bekannte Positionen von Matthew Balk
| Unternehmen | Position | Ende |
|---|---|---|
| ADAPTI, INC. | Direktor/Vorstandsmitglied | 25.10.2025 |
| VIVAKOR, INC. | Direktor/Vorstandsmitglied | 16.01.2023 |
| GRIDAI TECHNOLOGIES CORP. | Gründer | - |
Ausbildung von Matthew Balk
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
12
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Scepter Holdings, Inc.
 Scepter Holdings, Inc. Household/Personal CareConsumer Non-Durables Manufactures and sells consumer packaged goods | Consumer Non-Durables |
Vivakor, Inc.
 Vivakor, Inc. Chemicals: SpecialtyProcess Industries Operates as an asset acquisition company, which acquires technologies and assets in the fields of precious minerals, biotechnology and alternative energy | Process Industries |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entero Therapeutics, Inc.
 Entero Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures non-systemic therapies for the treatment of patients with gastrointestinal diseases | Health Technology |
